ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

IKNA Ikena Oncology Inc

1.74
-0.01 (-0.57%)
2024年6月18日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Ikena Oncology Inc IKNA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.01 -0.57% 1.74 09:00:00
始値 安値 高値 終値 前日終値
1.75 1.69 1.76 1.74 1.75
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1105:05EDGAR2Form 8-K - Current report
2024/5/2905:42GLOBEUPDATE – Ikena Oncology Announces Strategic Update
2024/5/2905:24EDGAR2Form 8-K - Current report
2024/5/2905:15GLOBEIkena Oncology Announces Strategic Update
2024/5/1405:45GLOBEIkena Oncology Reports First Quarter 2024 Financial Results..
2024/5/1405:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/4/1021:00GLOBEIkena Oncology to Present at the Stifel 2024 Virtual..
2024/3/1221:00GLOBEIkena Oncology Reports Fourth Quarter and Full Year 2023..
2024/3/0606:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/2722:00GLOBEIkena Oncology to Participate in TD Cowen 44th Annual Health..
2024/2/2206:29EDGAR2Form 8-K - Current report
2024/2/2206:15GLOBEIkena Oncology Appoints Caroline Germa, M.D. as Chief..
2024/2/0307:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0307:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1906:26EDGAR2Form 8-K - Current report
2024/1/1906:05GLOBEIkena Oncology Outlines Key Priorities and Provides..
2023/11/0921:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0921:09EDGAR2Form 8-K - Current report
2023/11/0921:00GLOBEIkena Oncology Shares Initial Positive and Differentiated..
2023/11/0722:00GLOBEIkena Oncology to Present at Multiple November 2023 Investor..
2023/10/1206:10EDGAR2Form 8-K - Current report
2023/9/2605:05EDGAR2Form DEF 14A - Other definitive proxy statements
2023/9/1605:05EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/9/1305:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/9/1113:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/9/0521:00GLOBEIkena Oncology to Participate in September 2023 Investor..
2023/8/1905:02EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/1021:00GLOBEIkena Oncology Reports Second Quarter 2023 Financial Results..
2023/8/1020:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0721:02EDGAR2Form 8-K - Current report
2023/8/0720:00GLOBEIkena Oncology Acquires Pionyr Immunotherapeutics in..
2023/7/0106:15EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock